Compare XHR & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XHR | ENOV |
|---|---|---|
| Founded | 2007 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Fluid Controls |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2014 | 2008 |
| Metric | XHR | ENOV |
|---|---|---|
| Price | $16.91 | $24.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | $15.67 | ★ $47.38 |
| AVG Volume (30 Days) | 673.7K | ★ 1.1M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.48% | N/A |
| EPS Growth | ★ 326.67 | N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $1,078,500,000.00 | N/A |
| Revenue This Year | $3.94 | $6.36 |
| Revenue Next Year | $2.68 | $5.31 |
| P/E Ratio | $80.50 | ★ N/A |
| Revenue Growth | ★ 3.80 | N/A |
| 52 Week Low | $11.64 | $21.00 |
| 52 Week High | $17.23 | $36.82 |
| Indicator | XHR | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 59.48 | 47.60 |
| Support Level | $14.26 | $23.81 |
| Resistance Level | $17.23 | $27.11 |
| Average True Range (ATR) | 0.43 | 1.54 |
| MACD | 0.00 | -0.11 |
| Stochastic Oscillator | 82.58 | 22.83 |
Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other regions. Xenia's revenue is divided between the sale of rooms, food and beverages, and other sources.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.